Explore
Active Stocks
Fri Mar 07 2025 15:59:38
  1. Tata Steel share price
  2. 151.55 0.80%
  1. Tata Motors share price
  2. 648.45 1.36%
  1. Reliance Industries share price
  2. 1,249.10 3.18%
  1. ITC share price
  2. 403.80 -0.48%
  1. HDFC Bank share price
  2. 1,687.00 -0.16%
Business News/ Companies / Companies News Today highlights on February 19, 2025: Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?
BackBack

Companies News Today highlights on February 19, 2025: Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?

1 min read . Updated: 19 Feb 2025, 05:30 AM IST
Livemint

Companies News Today highlights on February 19, 2025: Get the latest updates on the company's financial performance, strategic acquisitions, and market shifts. Explore detailed insights on mergers, acquisitions, financial results, and leadership changes that are shaping the business landscape across industries.

Companies News Today Live Updates: Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?Premium
Companies News Today Live Updates: Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?

Companies News Today highlights: Stay ahead of the curve with the latest insights from the corporate world through our company news coverage. This section provides a detailed look at significant events affecting industries and markets globally, including mergers, acquisitions, financial reports, and strategic shifts in leadership and operations. Whether you're an investor, a business professional, or simply interested in the dynamics of various industries, our reports offer a deep dive into the developments that shape the economic landscape. From startups to established giants, we bring you the news that matters to help you make informed decisions in a rapidly changing business environment.

Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.

19 Feb 2025, 05:30:21 AM IST

Company Business News Today Live: Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?

  • In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr. Reddy's Laboratories are shifting their focus to a promising new frontier: a weight loss drug modelled after Ozempic.
Read the full story here

Recommended For You

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

Yes, Continue

You are just one step away from creating your watchlist!

Login Now

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.

Your session has expired, please login again.

Yes, Continue